|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depletion and depreciation | |||||
| Share-based compensation expenses | |||||
| Changes in fair value of financial instruments | |||||
| Impairment reversal | |||||
| Gain on sale of royalty interest | |||||
| Gain on disposal of royalty interests | |||||
| Unrealized foreign exchange (gain) loss | |||||
| Deferred income tax expense | |||||
| Gain on sale of gold and silver bullion (Note 8) | |||||
| (Gain) loss on derivative financial instruments | |||||
| Other non-cash items | |||||
| Acquisition of gold bullion | |||||
| Gold and silver bullion from royalties received in-kind | |||||
| Proceeds from sale of gold and sliver bullion | |||||
| Proceeds from sale of gold and silver bullion | |||||
| Changes in other assets | |||||
| Operating cash flows before changes in non-cash working capital | |||||
| Changes in non-cash working capital: | |||||
| Increase in receivables | |||||
| Decrease (increase) in stream inventory, prepaid expenses and other | |||||
| Increase (decrease) in current liabilities | |||||
| (Increase) decrease in other current assets | |||||
| Increase in accounts payable and accrued liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows used in investing activities | |||||
| Acquisition of royalty, stream and working interests | |||||
| Proceeds from repayment of loan receivable | |||||
| Proceeds from sale of investments | |||||
| Acquisition of investments | |||||
| Advances of loans receivable | |||||
| Proceeds from disposal of royalty interests | |||||
| Acquisition of energy well equipment | |||||
| Acquisition of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows used in financing activities | |||||
| Payment of dividends | |||||
| Proceeds from draw down of Corporate Revolver | |||||
| Repayment of Corporate Revolver | |||||
| Proceeds from exercise of stock options | |||||
| Revolving credit facility amendment costs | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental cash flow information: | |||||
| Income taxes paid | |||||
| Dividend income received | |||||
| Interest and standby fees paid | |||||
Loading...